Inventor
KLAUS CHRISTINE
US17 patents
⚠️ This page may combine multiple inventors who share the name “KLAUS CHRISTINE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EPIZYME INC
15 patentsUS8765732B2Jul 1, 2014
Aryl- or heteroaryl-substituted benzene compounds
EPIZYME INC66 citations98
US9549931B2Jan 24, 2017
Aryl- or heteroaryl-substituted benzene compounds
EPIZYME INC39 citations97
US9522152B2Dec 20, 2016
Aryl- or heteroaryl-substituted benzene compounds
EPIZYME INC32 citations97
US9090562B2Jul 28, 2015
Aryl- or heteroaryl-substituted benzene compounds
EPIZYME INC51 citations97
US9855275B2Jan 2, 2018
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC18 citations94
US10420775B2Sep 24, 2019
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC12 citations92
US10155002B2Dec 18, 2018
Aryl- or heteroaryl-substituted benzene compounds
EPIZYME INC16 citations92
US9446064B2Sep 20, 2016
Combination therapy for treating cancer
EPIZYME INC22 citations89
US11052093B2Jul 6, 2021
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC7 citations84
US10525074B2Jan 7, 2020
Combination therapy for treating cancer
EPIZYME INC7 citations81
US12168016B2Dec 17, 2024
Aryl-OR heteroaryl-substituted benzene compounds
EPIZYME INC0 citations73
US12168015B2Dec 17, 2024
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC0 citations73
US12161645B2Dec 10, 2024
Aryl-or heteroaryl-substituted benzene compounds
EPIZYME INC0 citations73
US11642346B2May 9, 2023
Combination therapy for treating cancer
EPIZYME INC5 citations73
US11672800B2Jun 13, 2023
Combination therapies with EHMT2 inhibitors
EPIZYME INC5 citations72